Although the exact causes and mechanisms of this phenomenon have not yet been clarified, further studies should examine the role of Nrf2 activators as a therapeutic option for renal pathologies, including CIN, and establish safe and appropriate therapeutic indications for kidney disease54,55. Here, NFE2L2 is linked to cervical squamous intraepithelial neoplasia.